Literature DB >> 23962002

Hepatitis C virus NS5A protein modulates IRF-7-mediated interferon-α signaling.

Joydip Bhanja Chowdhury1, Hangeun Kim, Ranjit Ray, Ratna B Ray.   

Abstract

Hepatitis C virus (HCV) establishes chronic infection in a large number of infected individuals. We have previously shown that HCV infection in hepatocytes blocks poly (I-C) or interferon (IFN)-α-mediated IRF-7 nuclear translocation (Raychoudhuri and others 2010). However, the mechanism of IRF-7 regulation by HCV remained unknown. In this study, we have observed that HCV NS5A physically associates with IRF-7. A subsequent study suggested that the HCV NS5A protein blocks IRF-7-mediated IFN-α14 promoter activation. Further analyses demonstrated that site-specific mutagenesis of the 2 basic arginine residues (amino acids Arg(216) and Arg(217)) in the NS5A is critical for IRF-7-mediated IFN-α14 promoter regulation. Together, our results suggested that the HCV NS5A protein limits the IFN-α-signaling pathway in association with IRF-7, and may, in part, be responsible for the establishment of chronic infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23962002      PMCID: PMC3887440          DOI: 10.1089/jir.2013.0038

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  23 in total

Review 1.  Viruses and interferons.

Authors:  G C Sen
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

2.  Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.

Authors:  Hussein H Aly; Koichi Watashi; Makoto Hijikata; Hiroyasu Kaneko; Yasutugu Takada; Hiroto Egawa; Shinji Uemoto; Kunitada Shimotohno
Journal:  J Hepatol       Date:  2006-10-30       Impact factor: 25.083

Review 3.  An arms race: innate antiviral responses and counteracting viral strategies.

Authors:  M Schröder; A G Bowie
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

4.  Multiple alignment using hidden Markov models.

Authors:  S R Eddy
Journal:  Proc Int Conf Intell Syst Mol Biol       Date:  1995

5.  Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models.

Authors:  Emmanuel Thomas; Jordan J Feld; Qisheng Li; Zongyi Hu; Michael W Fried; T Jake Liang
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

6.  Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3.

Authors:  Xiaobo Lei; Zhenmin Sun; Xinlei Liu; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

7.  Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.

Authors:  Catherine B Bigger; Bernadette Guerra; Kathleen M Brasky; Gene Hubbard; Michael R Beard; Bruce A Luxon; Stanley M Lemon; Robert E Lanford
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

9.  Generation of infectious hepatitis C virus in immortalized human hepatocytes.

Authors:  Tatsuo Kanda; Arnab Basu; Robert Steele; Takaji Wakita; Jan S Ryerse; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

10.  Interferon signaling and treatment outcome in chronic hepatitis C.

Authors:  Magdalena Sarasin-Filipowicz; Edward J Oakeley; Francois H T Duong; Verena Christen; Luigi Terracciano; Witold Filipowicz; Markus H Heim
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-08       Impact factor: 11.205

View more
  8 in total

1.  Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.

Authors:  María Q Marín; Patricia Pérez; Carmen E Gómez; Carlos Óscar S Sorzano; Mariano Esteban; Juan García-Arriaza
Journal:  Viruses       Date:  2018-08-08       Impact factor: 5.048

Review 2.  Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease.

Authors:  Aleksandra Antonczyk; Bart Krist; Malgorzata Sajek; Agata Michalska; Anna Piaszyk-Borychowska; Martyna Plens-Galaska; Joanna Wesoly; Hans A R Bluyssen
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

Review 3.  Hepatitis C Virus Infection and Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors.

Authors:  Elrashdy M Redwan; Abdullah A Aljadawi; Vladimir N Uversky
Journal:  Biology (Basel)       Date:  2022-07-21

4.  Hepatitis C Virus Evades Interferon Signaling by Suppressing Long Noncoding RNA Linc-Pint Involving C/EBP-β.

Authors:  Mousumi Khatun; Jinsong Zhang; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

Review 5.  Hepatitis C virus infection: establishment of chronicity and liver disease progression.

Authors:  Young-Chan Kwon; Ratna B Ray; Ranjit Ray
Journal:  EXCLI J       Date:  2014-08-27       Impact factor: 4.068

6.  Classical swine fever virus NS5A protein changed inflammatory cytokine secretion in porcine alveolar macrophages by inhibiting the NF-κB signaling pathway.

Authors:  Xiao-Ying Dong; Sheng-Qiu Tang
Journal:  Virol J       Date:  2016-06-14       Impact factor: 4.099

Review 7.  Innate Immune Evasion Mediated by Flaviviridae Non-Structural Proteins.

Authors:  Shun Chen; Zhen Wu; Mingshu Wang; Anchun Cheng
Journal:  Viruses       Date:  2017-10-07       Impact factor: 5.048

8.  Human Herpesviruses Increase the Severity of Hepatitis.

Authors:  Kirill I Yurlov; Olga V Masalova; Lidiia B Kisteneva; Irina N Khlopova; Evgeny I Samokhvalov; Valentina V Malinovskaya; Vladimir V Parfyonov; Alexander N Shuvalov; Alla A Kushch
Journal:  Biology (Basel)       Date:  2021-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.